Clinical Trial Update: Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A completed Phase 1 trial evaluating the safety and dosing of the lapatinib and paclitaxel combination in patients with advanced solid tumors. The study spanned…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Brain and Central Nervous System Tumors
• Breast Cancer
• Esophageal Cancer
• Gastric Cancer
• Lung Cancer
• Ovarian Cancer
• Prostate Cancer

Drugs mentioned

• Lapatinib (Lapatinib)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: University of California, San Francisco | Conditions: Bladder Cancer, Brain and Central Nervous System Tumors | Phase 1 | Status: COMPLETED